Identifying and preparing for the challenges ahead

This tool is associated with the following interest areas: Industry, Sites

In 2019, more than 100 stakeholders met to discuss the challenges of rolling out gene therapy trials in the UK, and to identify what next steps should be taken by the whole DMD community, including doctors, industry professionals and patient advocacy groups. . 

You can read more about the discussions and conclusions in the Neuromuscular Disorders Journal. 

We have placed cookies on your computer to help make this website better. For more information please click here

By continuing to use this site or closing this panel, we'll assume you're OK to continue. You can view our full privacy policy here